Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)

0 Saves · 0 Shares · 2 Comments Discussion

Grant Name

Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)

Funder

National Institutes of Health (NIH)

Department of Health and Human Services (HHS)

Country or Region

United States

Research Field

Health

Deadline

Sep 05, 2025 12:00:00 AM EDT

Grant Size

$1,838,436

Contact Info

National Institutes of Health OERWebmaster03@od.nih.gov

Eligibility

Eligible Applicants:

Small businesses

Additional Information on Eligibility:

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Grant Number

PAS-22-196

Description

This Funding Opportunity Announcement (FOA) invites applications to the National Institute on Aging's (NIA) Small Business Innovation Research (SBIR) program. The aim of this FOA is to support research that may lead to the development of innovative products and/or services that have the potential to advance progress in preventing and treating Alzheimer's disease (AD) and AD-related dementias (ADRD) and/or caring for and treating patients living with AD/ADRD.

Website

http://grants.nih.gov/grants/guide/pa-files/PAS-22-196.html

Funding resources
Purdue Grant Writing Lab: Introduction to Grant Writing	Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	Open Link

Quick share

Add deadline to calendar

Sep 05, 2025 12:00:00 AM EDT

Have a funding opportunity that you want to list here?

Submit the grant details to support@peeref.com for review and listing.

Suggest reading

Empowering Innovation: A Spotlight on the National Science Foundation

Organizational Spotlight: The American Geophysical Union (AGU)

Top 10 Engineering Schools in Europe 2023

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

Related opportunities

Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed): Health Sep 13, 2024 12:00:00 AM EDT $500,000

NIOSH Centers for Agricultural Safety and Health: Health Dec 01, 2024 12:00:00 AM EST $2,200,000

Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed): Health Jan 17, 2025 12:00:00 AM EST $325,000

Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional): Health May 28, 2025 12:00:00 AM EDT $1,500,000

Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed): Health Jun 06, 2025 12:00:00 AM EDT $295,924

Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional): Health Sep 05, 2025 12:00:00 AM EDT $1,838,436

MOMENTUM (Moving integrated, quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health services to scale): Targeted MNCH/FP/RH technical assistance to private providers: Medicine September 30, 2025 Up to 75,000,000 USD

MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health Services to Scale): Medicine September 30, 2025 Up to 25,000,000 USD

MRFF 2022 Frontier Health and Medical Research Grant Opportunity: Health and Medical Research 31-Mar-2026 $400,000,000.00

© Peeref 2019-2024. All rights reserved.